Company Overview and News

0
Jaypee Infratech Limited - Resignation

2018-08-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
533207 JPINFRATEC

0
Jaypee Infratech Limited - Corporate Insolvency Resolution Process

2018-08-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
533207 JPINFRATEC

0
D-Street Buzz: Pharma, FMCG stocks gain led by Cadila Health ITC; Infosys hits new record high

2018-08-17 moneycontrol
The Indian benchmark indices this Friday morning are trading on a bullish note with the Nifty jumping 66 points at 11, 451 while the Sensex rallied 244 points and is trading at 37,907.
HINDCOPPER AUROPHARMA 500228 UBL HNDZY 511389 VIDEOIND 532478 CADILAHC 535789 532321 500470 533207 506690 UNICHEMLAB HINDALCO 524804 IDKQY UBHOLDINGS 513599 CANFINHOME 511196 UNBWY JSWSTEEL CDLYY VTL IBULHSGFIN HNDNF TTST BATAINDIA TATASTEEL JPINFRATEC TATLY ARBQY 502986 507458 500043 500440 500188 HINDZINC

0
81 firms under NSE ASM framework

2018-08-17 freepressjournal.in
New Delhi : As many as 81 firms have come under the Additional Surveillance Measure (ASM) framework of the NSE, according to the latest data available with the exchange.
ESL SHILPI AMKD MOREPENLAB EMAMIINFRA AMTEKAUTO ZENITHEXPO 531723 532513 532997 UTTAMVALUE IDBLZ 531543 512553 532775 GTLINFRA 534976 532960 JINDWORLD 533207 RADICO KSK 500254 IBVENTURES 533264 ZENTEC 533389 539207 TVSELECT VMART 532497 533218 533339 JPINFRATEC 500288 STAMPEDE 520077 MANPASAND

0
SC orders fresh resolution process against Jaypee Infra

2018-08-10 freepressjournal.in
Mumbai : In a setback to the Jaypee Group, the Supreme Court on Thursday ordered re-commencement of resolution process against Jaypee Infratech and barred the firm, its holding company and their promoters from participating in the fresh bidding process.
532532 533207 JPINFRATEC JIPKY JPASSOCIAT

0
Home for family is a basic ‘human yearning’, says Supreme Court

2018-08-09 freepressjournal.in
New Delhi: The Supreme Court today observed that having a house for a family was a “basic human yearning” wherein hard earned money was invested in the hope of obtaining a roof over their heads. A bench headed by Chief Justice Dipak Misra made the observation in a verdict in which the apex court ordered re-commencement of resolution process against Jaypee Infratech Ltd (JIL) and barred the firm, its holding company and their promoters from participating in the fresh bidding process.
532532 533207 JPINFRATEC JIPKY JPASSOCIAT

0
SC asks National Company Law Tribunal to deal with insolvency proceedings against Jaypee Infratech Ltd

2018-08-09 freepressjournal.in
New Delhi: In a setback to the Jaypee group, the Supreme Court today asked the National Company Law Tribunal (NCLT), Allahabad, to deal with the insolvency proceedings against Jaypee Infratech Ltd (JIL) and barred the group or its promoters from participating in the fresh bidding process.
533207 JPINFRATEC

0
Rajya Sabha Deputy Chairman election: NDA candidate Harivansh Narayan Singh elected with 125 votes

2018-08-09 freepressjournal.in
New Delhi: NDA candidate and JD(U) member Harivansh Narayan Singh was today elected as Rajya Sabha Deputy Chairman, defeating opposition’s B K Hariprasad. Rajya Sabha Chairman M Venkaiah Naidu initiated the process of the election by calling for division of votes in the House. While Harivansh Narayan Singh secured 125 votes, Hariprasad got 105.
533207 JPINFRATEC

0
NCLT to hear insolvency proceedings against Jaypee

2018-08-09 livemint
New Delhi: In a setback to the Jaypee group, the Supreme Court on Thursday asked the National Company Law Tribunal (NCLT), Allahabad, to deal with insolvency proceedings against Jaypee Infratech Ltd (JIL), and barred the group and its promoters from participating in fresh bidding process.
533207 500116 JPINFRATEC IDBI

0
Ill-timed, poorly assessed loan to Jaypee caused over Rs 1,000 crore NPA: CAG raps IIFCL

2018-08-07 moneycontrol
An ill-timed and loosely assessed loan of Rs 900 crore to Jaypee Infratech Ltd hit the Yamuna Expressway Project over a period of time, causing a build-up of bad assets worth over Rs 1,000 crore on the books of IIFCL, a CAG report observed.
533207 JPINFRATEC

0
Bankruptcy code amendments offer some hope to troubled home buyers

2018-08-02 livemint
New Delhi: Granting home buyers financial creditor status and opening up new streams of finance for completing halted projects under the amended bankruptcy code are set to offer relief to consumers.
533207 JPINFRATEC

0
Jaypee Infratech Q1 loss widens to Rs 298 cr

2018-07-31 moneycontrol
Bankruptcy-bound Jaypee Infratech today reported a net loss of Rs 298.33 crore for the first quarter this fiscal. Its net loss stood at Rs 44.78 crore in the year-ago period, the company said in a regulatory filing.
533207 500116 JPINFRATEC IDBI

0
Jaiprakash Associates posts Rs 285 cr loss for Q1 FY19

2018-07-30 moneycontrol
Debt-ridden Jaiprakash Associates Ltd (JAL) today reported a standalone net loss of Rs 285.02 crore for the first quarter of this financial year. Its net profit stood at Rs 764.99 crore in the year-ago period, the company said in a regulatory filing.
532532 533207 500116 JPINFRATEC JIPKY IDBI JPASSOCIAT

0
Jaypee Infratech Limited - Press Release

2018-07-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
533207 JPINFRATEC

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...